Web Analytics
Albireo wins FDA approval of IND to start Elobixibat Phase 2 Trial

Albireo wins FDA approval of IND to start Elobixibat Phase 2 Trial

<

Albireo wins FDA approval of IND to start Elobixibat Phase 2 Trial

Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH

Albireo Pharma, Inc. (ALBO) Q1 2019 Earnings Call Transcript -- The Motley Fool

Ziopharm's Controlled IL-12 program gets FDA Fast Track Designation

www.frontiersin.org

Everlife buys stake in CPC Diagnostics to grow presence in India

Biogen freezes two Alzheimer's drug trials owing to failed outcomes

www.frontiersin.org

US FDA steps up efforts to evaluate materials in medical devices

Menlo Therapeutics gets Serlopitant Phase 2 data published in JAAD

Cast Your Vote

Novartis locks horns with Amgen on migraine drug partnership

Download figure · Open in new tab ...

Biogen freezes two Alzheimer's drug trials owing to failed outcomes | Healthcare Opportunity | Frozen two, Table Lamp, Lighting

www.frontiersin.org

str1

Download figure · Open in new tab ...

PRECLINICAL- 4-quinolone prodrugs, pP4Q-414 , potential treatment of multi-drug resistant Plasmodium falciparum malaria

str1

www.frontiersin.org

Lupin's NaMuscla gets EU approval to treat myotonia in adults with NDM | Healthcare Opportunity | Health care, Treats, Opportunity

www.frontiersin.org

Public domain antibiotic found highly effective against triple-negative breast cancer

Patent

Lupin's NaMuscla gets EU approval to treat myotonia in adults with NDM

Download figure · Open in new tab ...

A prostate cancer drug won't be offered on the NHS

www.frontiersin.org

Image result for Goofice

Glenmark to commercialize nasal spray Ryaltris in South Korea

Heart failure drug piques interest, but not yet winning hearts

Dr. Reddy's Laboratories Managing Director and Chief Operating Officer Satish Reddy addressing

Targeting triple-negative breast cancer with new drug design

Glenmark to commercialize nasal spray Ryaltris in South Korea | Healthcare Opportunity | Korea, South Korea, Health care

Patent

First US stem cell trial for autistic children launches today

GENFIT to yield additional Elafibranor clinical trial data at 2019 ILC

BrainStorm Cell Therapeutics to expand NurOwn manufacturing capacity

Roche, Merck to jointly develop pan-cancer companion diagnostic test

Innovent, Incyte collaborate on three clinical trial-stage products

Sanofi's insulin prices for some patients in U.S. topple to $99/month

DJO announces plans to relocate global HQ from San Diego to Dallas

Dr. Reddy's goes on to launch Sevelamer Carbonate in the U.S. market

Genetic Technologies, Blockshine ink biomedical blockchain partnership

Atlas Venture bags $250 million for its first opportunity fund

Taisho reportedly close to buying Bristol-Myers's UPSA in a $1.6B deal

Amgen and Molecular Partners collaborate to advance Immuno-Oncology

INTEROPen & Digital Health team up to promote interoperability

Apple partners with J Opportunity, Cookie Cutters, Study, Apple, Cookies, Lighting

First two-drug regimen approved for HIV-1 treatment

in_the_clinic.jpg

Modern Pharmaceuticals - July 2011

E.l.f. Posts Improvement After Implementing Project Unicorn

Albireo wins FDA approval of IND to start Elobixibat Phase 2 Trial | Healthcare Opportunity | Company logo, Logos, Tech companies

Glenmark Pharmaceuticals obtains U.S. FDA approval for its ear drops

Australian Pharmaceutical Industries plans to acquire Sigma Healthcare

AlphaStreet Logo

Antengene Corp. bags $120 million in Series B financing round

Conceptual image of the field trial

Addiction to prescription opioids has reached a crisis level in

Although people with PTSD can receive help from psychotherapists and antidepressants, drugs to specifically treat the disorder are lacking, as a feature in ...

J&J to pay ₹75 lakh to patient in compensation for faulty hip implant

The compound is a novel macrocyclic antibiotic that is produced by fermentation. Its narrow-spectrum activity is highly selective for C. difficile, ...

Lansdowne Yonkers FC

Biotech companies will become more accepting of the idea that their peak valuations from last summer

Catalyst Pharma, Endo Ventures sign agreement for vigabatrin tablets

Coty CEO Stresses Simplification as Part of Turnaround

Achilles Therapeutics wins CTA approval for study of its NSCLC therapy

HEADLINE NEWS Novartis Drug Discovery Centralization Brings R&D Relocations, Job Cuts STEN STOVALL sten.

Fibrocell's azficel-T enters phase II trial for burn scars

Cambridge researchers develop new VR system to view cancer cells in 3D

Modern Medicare - January 2011

Shorter treatment for Chagas disease could be just as effective, and significantly safer

Effective campaigns increasingly have PR 'baked in' - TV-led and video-led - two different models - The use of partnerships is on the rise

IN THIS ISSUE Rationalization is the latest move by Novartis to concentrate R&D efforts Teva is

DRUG BEING RELEASED FROM HEAT ACTIVATED LIPOSOME

Mercedes Javid Reveals Her Plans for Her First Mother's Day: 'We Love Being at Home with the Baby'

QIAGEN acquires N-of-One, expands medical bioinformatics abilities

Cancer drug in the works might double as reversible male contraceptive

Mobidiag declares JV with Autobio for commercializing Novodiag®

Oil painting of the Kawasaki factory from the 1910s

Researchers have identified a gene that, when repressed in tumor cells, puts a halt to cell growth and a range of processes needed for tumors to enlarge and ...

Modern Pharmaceuticals - April 2011

A study published online today in Nature from researchers in the US and Thailand should help scientists inch closer to settling that debate.

An electric tongue can handle more spicy foods than you can

Gala Pharmaceutical awarded temporary cannabis testing State License

QIAGEN acquires N-of-One, expands medical bioinformatics abilities | Healthcare Opportunity | Health care, Medical, Opportunity

AstraZeneca Says 2023 Brilinta Forecast Now Unattainable AstraZeneca will cut its sales forecasts for Brilinta after

JCB will conduct a pilot trial of its Biometrics Card with fingerprint, with IDEMIA, a global Augmented Identity leader, and Toppan Printing.

Tien Chu Ve-Tsin

Motoko-chan no Wonder Kitchen

After completion of temperature cycling process, the slurry was filtered under suction, followed by drying in air tray dryer (ATD) at 40°C to a constant ...

Lupin, AbbVie partner to develop & commercialize new oncology drug

Celebrities Who Happily Dumped Their Diets

Morris Museum of Art

com It s no secret that deal making this year has fallen short of 2014 and

YLYstudio

Researchers develop disposable paper sensors to monitor blood sugar

Ajinomoto Stadium